AMANDA DELANEY: Open Payments
NPI 1295234847 · WENTZVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$145 in 9 payments from 6 companies in 2025. Trend: 2023 $622 · 2024 $1,122 · 2025 $145
Food & beverage: $145
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| GENZYME CORPORATION | 2 | $37 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Organon LLC | 1 | $1 |
Products named: FASENRA, DUPIXENT, NEFFY, EBGLYSS, NUCALA, AIRSUPRA, VTAMA.
Industry payments across MO — which companies pay providers there.
